ID

13635

Descripción

Oral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's Lymphomas; ODM derived from: https://clinicaltrials.gov/show/NCT00003113

Link

https://clinicaltrials.gov/show/NCT00003113

Palabras clave

  1. 22/2/16 22/2/16 -
Subido en

22 de febrero de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Lymphoma NCT00003113

Eligibility Lymphoma NCT00003113

  1. StudyEvent: Eligibility
    1. Eligibility Lymphoma NCT00003113
Criteria
Descripción

Criteria

biopsy proven stage i through iv intermediate to high grade non-hodgkin's lymphoma of b-cell, t-cell, or indeterminate immunologic phenotype
Descripción

NHL of various kinds

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0024305
measurable or evaluable
Descripción

measurable or evaluable

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1513041
UMLS CUI [2]
C1516986
no cytologic or radiographic evidence of cns lymphoma
Descripción

cns lymphoma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0280803
60 and over
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
performance status: ecog 0-3
Descripción

performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
life expectancy: at least 6 weeks
Descripción

life expectancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023671
wbc at least 1500/mm3
Descripción

wbc

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023508
platelet count at least 50,000/mm3
Descripción

platelets

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0005821
bilirubin no greater than 3.0 mg/dl
Descripción

bilirubin

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1278039
creatinine no greater than 3.0 mg/dl
Descripción

creatinine

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201976
no prior chemotherapy
Descripción

chemotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0392920
prior radiotherapy allowed for localized stage i or ii disease that has progressed beyond initial radiotherapy ports
Descripción

radiotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1522449

Similar models

Eligibility Lymphoma NCT00003113

  1. StudyEvent: Eligibility
    1. Eligibility Lymphoma NCT00003113
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
NHL of various kinds
Item
biopsy proven stage i through iv intermediate to high grade non-hodgkin's lymphoma of b-cell, t-cell, or indeterminate immunologic phenotype
boolean
C0024305 (UMLS CUI [1])
measurable or evaluable
Item
measurable or evaluable
boolean
C1513041 (UMLS CUI [1])
C1516986 (UMLS CUI [2])
cns lymphoma
Item
no cytologic or radiographic evidence of cns lymphoma
boolean
C0280803 (UMLS CUI [1])
Age
Item
60 and over
boolean
C0001779 (UMLS CUI [1])
performance status
Item
performance status: ecog 0-3
boolean
C1520224 (UMLS CUI [1])
life expectancy
Item
life expectancy: at least 6 weeks
boolean
C0023671 (UMLS CUI [1])
wbc
Item
wbc at least 1500/mm3
boolean
C0023508 (UMLS CUI [1])
platelets
Item
platelet count at least 50,000/mm3
boolean
C0005821 (UMLS CUI [1])
bilirubin
Item
bilirubin no greater than 3.0 mg/dl
boolean
C1278039 (UMLS CUI [1])
creatinine
Item
creatinine no greater than 3.0 mg/dl
boolean
C0201976 (UMLS CUI [1])
chemotherapy
Item
no prior chemotherapy
boolean
C0392920 (UMLS CUI [1])
radiotherapy
Item
prior radiotherapy allowed for localized stage i or ii disease that has progressed beyond initial radiotherapy ports
boolean
C1522449 (UMLS CUI [1])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial